Nicotinamide and Lanthanum Carbonate and Changes in Serum Phosphate and Fibroblast Growth Factor-23 in Patients With CKD: The COMBINE Trial Inclusion criteria for this randomized, double-blind, ...

Online survey findings showed significant challenges with compliance to phosphate binder therapy. Among 200 dialysis patients, 37% were non-compliant with their phosphate binders compared with 12% to ...

Fixed-Dose Phosphate Binder Schedules May Be Less than Ideal Study of peritoneal dialysis patients showed that they do not adjust binders to match the phosphate content of meals and snacks. Phosphate ...

Few areas related to the care of patients on dialysis have generated more controversy than the use of phosphate binders. The current debate regarding use of calcium-based versus non-calcium-based ...

Compared with calcium-based phosphate binders, non-calcium-based phosphate binders are associated with a lower risk for all-cause mortality in patients with chronic kidney disease (CKD), according to ...

ORLANDO, Fla.—Proton pump inhibitors (PPIs) taken concurrently with phosphate binders may increase phosphate control in hemodialysis (HD) patients, according to researchers. A team based at New York ...

Whether use of non-calcium-containing phosphate binders versus calcium-containing phosphate binders improves outcomes for patients with chronic kidney disease is unclear. Now, new data from an ...

LOS ALTOS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the ...

– Patient-reported outcomes from Phase 2 trial of oxylanthanum carbonate (OLC) demonstrate high patient satisfaction with OLC compared to their prior phosphate lowering therapy – – Findings from a ...